Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A02488 | Pages: 295 | Charts: 65 | Tables: 156 |
The global lateral flow assay market was valued at $8,351.30 million in 2020 and is projected to reach $13,352.90 million by 2030 registering a CAGR of 4.70% from 2021 to 2030.
Lateral flow assays (LFA), also known as lateral flow immunochromatographic assays, are techniques used to detect presence (or absence) of a target analyte in a sample (matrix). These assays are widely used in hospitals and clinical laboratories for qualitative and quantitative detection of specific antigens and antibodies. Furthermore, lateral flow assay kits are used to rapidly test for infectious diseases, cardiac markers, pregnancy & fertility, cholesterol testing/lipid profiling, and drug abuse. They are also used for testing food & beverages.
Get more information on this report : Request Sample Pages
Growth in the lateral flow assays market is mainly driven by factors such as spread of various chronic and infectious diseases, increase in use of home-based lateral flow assay kits, growth in government initiatives toward promoting health awareness, growth in demand for point-of-care testing, increase in adoption of LFA due to innovations and advantages of LFA rapid tests over laboratory tests. Moreover, recent outbreak of the COVID-19 has positively affected growth of the lateral flow assays market. However, stringent and time-consuming regulatory policies for assays performed to detect presence or absence of any analyte and unwillingness of people toward changing existing medical practices restrain the market growth. Advancements in technology and increase in applications of lateral flow assay tests in clinical diagnostics provide lucrative opportunities for the lateral flow assay market growth.
Lateral flow assays (LFA) market has seen considerable growth due to the COVID-19 pandemic. Lateral flow assay-based tests are being used worldwide for diagnosing COVID-19 infections as LFA test kits have demonstrated the potential to detect both symptomatic and asymptomatic COVID-19 infections. Many healthcare companies are focused on developing lateral flow assay devices that can detect patient antibodies (IgG and IgM) or COVID-19 viral antigens in blood samples using a finger prick, saliva samples, or nasal fluid swabs. Factors that boost demand for LFA-based devices for COVID-19 testing include low cost of LFA devices and the fact that no trained personnel are required for performing these tests. The potential of LFA devices in detecting symptomatic and asymptomatic COVID-19 infections is its main advantage over other detection methods. For instance, RT-PCR can only determine active infections in patients, whereas LFA-based testing devices can determine patients who are asymptomatic, have been cured of the infection, and are no longer at risk of spreading the virus to others. Furthermore, LFA-based tests can diagnose different stages of COVID-19 infection in a patient. Hence, to a large extent, LFA-based tests shape medical and economic decisions for countries that continue to be affected by the COVID-19 pandemic and those preparing for the third wave in the future.
The lateral flow assay market is segmented on the basis of product, technique, application, end user, and region. By technique, the market is classified into competitive assay, sandwich assay, and multiplex detection assay. By product, it is bifurcated into lateral flow readers and kits & reagents. The lateral flow readers segment is further sub segmented into digital/mobile readers, mobile/smartphone readers, and benchtop readers. Applications covered in the study include veterinary diagnostics, clinical testing, food safety & environment testing, and drug development & quality testing. The clinical testing segment is further divided into infectious disease testing, cardiac marker testing, pregnancy & fertility testing, cholesterol & lipid testing, drugs-of-abuse testing, and others. According to end user, the market is segmented into home care, diagnostic laboratories, hospitals & clinics, pharmaceutical & biotechnology companies and others.. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By technique, the sandwich assays segment accounted for the largest share of the lateral flow assay kits & reagents market. Wide applications of these assays in clinical testing and advantages associated with the use of these assays, such as higher sensitivity and specificity for larger analytes are the major factors that drive growth of the sandwich assays market.
[TECHNIQUEGRAPH]
Get more information on this report : Request Sample Pages
By product, the lateral flow readers segment is expected to grow at the highest CAGR in the market. It allows quantitative analysis of lateral flow strips in sandwich, competitive, and reverse-competitive test formats. Readers measure intensity of the test line to determine quantity of analytes in samples and provide a fully quantitative assay result. Readers perform multiple readings from a single device or a single read for multiple devices, followed by automatic statistical analysis of results to give a consolidated value. Moreover, lateral flow readers are highly sensitive and can quantify and accurately capture and transmit data. These factors promote high growth of this segment.
[PRODUCTGRAPH]
Get more information on this report : Request Sample Pages
North America is expected to dominate the overall LFA market throughout the forecast period, owing to rise in incidences of various infectious diseases such as Lyme disease, COVID-19, tuberculosis, and increased mortality rate associated with HIV/AIDS in the region. In North America, the U.S holds the largest market share, owing to increased patient pool and high affordability with increasing disposable income.
[COUNTRYGRAPH]
Get more information on this report : Request Sample Pages
The key market players profiled in the report include Abbott Laboratories, Danaher Corporation, F. Hoffmann-La Roche AG, Siemens Healthineers AG, Becton, Dickinson and Company, bioMérieux SA, Bio-Rad Laboratories, Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., and PerkinElmer Inc.
Key Benefits For Stakeholders
Key Market Segments
Key Market Players
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY'
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.High prevalence of infectious diseases across the globe
3.5.1.2.Increasing usage of home based lateral flow assay kit
3.5.1.3.Growing demand for point-of-care testing
3.5.2.Restraints
3.5.2.1.Lower accuracy of lateral flow assay tests
3.5.2.2.Limited reimbursements for lateral flow assay products
3.5.3.Opportunity
3.5.3.1.Evolving applications of lateral flow assays
3.5.4.Impact analysis
3.6.Covid-19 Impact analysis on lateral flow assay market
CHAPTER 4:LATERAL FLOW ASSAY MARKET, BY TECHNIQUE
4.1.Overview
4.1.1.Market size and forecast
4.2.Sandwich assays
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Competitive Assays
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
4.4.Multiplex detection assays
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast
4.4.3.Market analysis, by country
CHAPTER 5:LATERAL FLOW ASSAY , BY PRODUCT
5.1.Overview
5.1.1.Market size and forecast
5.2.Kits & Reagents
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Lateral Flow Readers
5.3.1.Market size and forecast
5.3.2.Market analysis, by country
5.3.3.Market size and forecast, by type
5.3.3.1.Digital/Mobile Readers
5.3.3.1.1.Market size and forecast
5.3.3.2.Benchtop Readers
5.3.3.2.1.Market size and forecast
5.3.3.3.Mobile/Smartphone Readers
5.3.3.3.1.Market size and forecast
CHAPTER 6:LATERAL FLOW ASSAY , BY APPLICATION
6.1.Overview
6.1.1.Market size and forecast
6.2.Clinical testing
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.2.3.Market size and forecast, by type
6.2.3.1.Infectious Disease Testing
6.2.3.1.1.Market size and forecast
6.2.3.2.Cardiac Marker Testing
6.2.3.2.1.Market size and forecast
6.2.3.3.Pregnancy & Fertility Testing
6.2.3.3.1.Market size and forecast
6.2.3.4.Cholesterol Testing/Lipid Profile
6.2.3.4.1.Market size and forecast
6.2.3.5.Drug Abuse Testing
6.2.3.5.1.Market size and forecast
6.2.3.6.Other Clinical Tests
6.2.3.6.1.Market size and forecast
6.3.Veterinary Diagnostics
6.3.1.Market size and forecast
6.3.2.Market analysis, by country
6.4.Food safety & environment testing
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
6.5.Drug Development & Quality Testing
6.5.1.Market size and forecast
6.5.2.Market analysis, by country
CHAPTER 7:LATERAL FLOW ASSAY , BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospitals & Clinics
7.2.1.Market size and forecast, by region
7.2.2.Market analysis, by country
7.3.Diagnostic Laboratories
7.3.1.Market size and forecast, by region
7.3.2.Market analysis, by country
7.4.Home Care
7.4.1.Market size and forecast, by region
7.4.2.Market analysis, by country
7.5.Pharmaceutical & Biotechnology Companies
7.5.1.Market size and forecast, by region
7.5.2.Market analysis, by country
7.6.Other End Users
7.6.1.Market size and forecast, by region
7.6.2.Market analysis, by country
CHAPTER 8:LATERAL FLOW ASSAY MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by country
8.2.2.1.U.S. Lateral flow assay market, by technique
8.2.2.2.U.S. Lateral flow assay market, by Product
8.2.2.3.U.S. Lateral flow assay market, by Application
8.2.2.4.U.S. Lateral flow assay market, by end user
8.2.2.5.Canada Lateral flow assay market, by technique
8.2.2.6.Canada Lateral flow assay market, by Product
8.2.2.7.Canada Lateral flow assay market, by Application
8.2.2.8.Canada Lateral flow assay market, by end user
8.2.2.9.Mexico Lateral flow assay market, by technique
8.2.2.10.Mexico Lateral flow assay market, by Product
8.2.2.11.Mexico Lateral flow assay market, by Application
8.2.2.12.Mexico Lateral flow assay market, by end user
8.2.3.North America market size and forecast, by technique
8.2.4.North America market size and forecast, by product
8.2.5.North America market size and forecast, by application
8.2.6.North America market size and forecast, by end user
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany Lateral flow assay market, by technique
8.3.2.2.Germany Lateral flow assay market, by Product
8.3.2.3.Germany Lateral flow assay market, by Application
8.3.2.4.Germany Lateral flow assay market, by end user
8.3.2.5.France Lateral flow assay market, by technique
8.3.2.6.France Lateral flow assay market, by Product
8.3.2.7.France Lateral flow assay market, by Application
8.3.2.8.France Lateral flow assay market, by end user
8.3.2.9.UK Lateral flow assay market, by technique
8.3.2.10.UK Lateral flow assay market, by Product
8.3.2.11.UK Lateral flow assay market, by Application
8.3.2.12.UK Lateral flow assay market, by end user
8.3.2.13.Italy Lateral flow assay market, by technique
8.3.2.14.Italy Lateral flow assay market, by Product
8.3.2.15.Italy Lateral flow assay market, by Application
8.3.2.16.Italy Lateral flow assay market, by end user
8.3.2.17.Spain Lateral flow assay market, by technique
8.3.2.18.Spain Lateral flow assay market, by Product
8.3.2.19.Spain Lateral flow assay market, by Application
8.3.2.20.Spain Lateral flow assay market, by end user
8.3.2.21.Rest of Europe
8.3.2.22.Rest of Europe Lateral flow assay market, by technique
8.3.2.23.Rest of Europe Lateral flow assay market, by Product
8.3.2.24.Rest of Europe Lateral flow assay market, by Application
8.3.2.25.Rest of Europe Lateral flow assay market, by end user
8.3.3.Europe market size and forecast, by technique
8.3.4.Europe market size and forecast, by product
8.3.5.Europe market size and forecast, by application
8.3.6.Europe market size and forecast, by end user
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.Japan Lateral flow assay market, by technique
8.4.2.2.Japan Lateral flow assay market, by Product
8.4.2.3.Japan Lateral flow assay market, by Application
8.4.2.4.Japan Lateral flow assay market, by end user
8.4.2.5.China Lateral flow assay market, by technique
8.4.2.6.China Lateral flow assay market, by Product
8.4.2.7.China Lateral flow assay market, by Application
8.4.2.8.China Lateral flow assay market, by end user
8.4.2.9.Australia Lateral flow assay market, by technique
8.4.2.10.Australia Lateral flow assay market, by product
8.4.2.11.Australia Lateral flow assay market, by application
8.4.2.12.Australia Lateral flow assay market, by end user
8.4.2.13.India Lateral flow assay market, by technique
8.4.2.14.India Lateral flow assay market, by product
8.4.2.15.India Lateral flow assay market, by application
8.4.2.16.India Lateral flow assay market, by end user
8.4.2.17.Rest of Asia-Pacific
8.4.2.18.Rest of Asia-Pacific Lateral flow assay market, by technique
8.4.2.19.Rest of Asia-Pacific Lateral flow assay market, by product
8.4.2.20.Rest of Asia-Pacific Lateral flow assay market, by application
8.4.2.21.Rest of Asia-Pacific Lateral flow assay market, by end user
8.4.3.Asia-Pacific market size and forecast, by technique
8.4.4.Asia-Pacific market size and forecast, by product
8.4.5.Asia-Pacific market size and forecast, by application
8.4.6.Asia-Pacific market size and forecast, by end user
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil Lateral flow assay market, by technique
8.5.2.2.Brazil Lateral flow assay market, by product
8.5.2.3.Brazil Lateral flow assay market, by application
8.5.2.4.Brazil Lateral flow assay market, by end user
8.5.2.5.Saudi Arabia Lateral flow assay market, by technique
8.5.2.6.Saudi Arabia Lateral flow assay market, by product
8.5.2.7.Saudi Arabia Lateral flow assay market, by application
8.5.2.8.Saudi Arabia Lateral flow assay market, by end user
8.5.2.9.South Africa Lateral flow assay market, by technique
8.5.2.10.South Africa Lateral flow assay market, by product
8.5.2.11.South Africa Lateral flow assay market, by application
8.5.2.12.South Africa Lateral flow assay market, by end user
8.5.2.13.Rest of LAMEA Lateral flow assay market, by technique
8.5.2.14.Rest of LAMEA Lateral flow assay market, by product
8.5.2.15.Rest of LAMEA Lateral flow assay market, by application
8.5.2.16.Rest of LAMEA Lateral flow assay market, by end user
8.5.3.LAMEA market size and forecast, by technique
8.5.4.LAMEA market size and forecast, by product
8.5.5.LAMEA market size and forecast, by application
8.5.6.LAMEA market size and forecast, by end user
CHAPTER 9:COMPANY PROFILES
9.1.ABBOTT LABORATORIES
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.1.6.Key strategic moves and developments
9.2.BECTON, DICKINSON AND COMPANY
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.2.6.Key strategic moves and developments
9.3.BIOMÉRIEUX, INC.
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments
9.4.BIO-RAD LABORATORIES, INC.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.4.6.Key strategic moves and developments
9.5.DANAHER CORPORATION
9.5.1.Company overview
9.5.2.ompany snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Business performance
9.5.6.Key strategic moves and developments
9.6.F. HOFFMANN-LA ROCHE LTD.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.6.6.Key strategic moves and developments
9.7.HOLOGIC, INC.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.7.5.Business performance
9.7.6.Key strategic moves and developments
9.8.PERKINElMER, INC.
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.8.6.Key strategic moves and developments
9.9.SIEMENS AG
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.9.6.Key strategic moves and developments
9.10.THERMO FISHER SCIENTIFIC, INC.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
9.10.6.Key strategic moves and developments
LIST OF TABLES
TABLE 01.LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030($MILLION)
TABLE 02.SANDWICH ASSAYS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 03.COMPETITIVE ASSAYS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 04.MULTIPLEX DETECTION ASSAYS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 05.LATERAL FLOW ASSAY , BY PRODUCT, 2020–2030($MILLION)
TABLE 06.KITS & REAGENTS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 07.LATERAL FLOW READERS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 08.BETA LACTAM & BETA LACTAMASE INHIBITORS, BY TYPE, 2019–2027 ($MILLION)
TABLE 09.LATERAL FLOW ASSAY , BY APPLICATION, 2020–2030($MILLION)
TABLE 10.CLINICAL TESTING LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 11.LATERAL FLOW ASSAY MARKET, FOR CLINICAL TESTING, BY TYPE, 2020–2030, ($MILLION)
TABLE 12.VETERINARY DIAGNOSTICS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 13.FOOD SAFETY & ENVIRONMENT TESTING LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 14.DRUG DEVELOPMENT & QUALITY TESTING LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 15.LATERAL FLOW ASSAY , BY PRODUCT, 2020–2030($MILLION)
TABLE 16.HOSPITALS & CLINICS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 17.DIAGNOSTIC LABORATORIES LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 18.HOME CARE LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 19.PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 20.OTHER END USERS LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 21.LATERAL FLOW ASSAY MARKET, BY REGION, 2020–2030($MILLION)
TABLE 22.NORTH AMERICA LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 23.U.S. LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 24.U.S. LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 25.U.S. LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 26.U.S. LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 27.CANADA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 28.CANADA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 29.CANADA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 30.CANADA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 31.MEXICO LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 32.MEXICO LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 33.MEXICO LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 34.MEXICO LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 35.NORTH AMERICA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 36.NORTH AMERICA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 37.NORTH AMERICA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 38.NORTH AMERICA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 39.EUROPE LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 40.GERMANY LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 41.GERMANY LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 42.GERMANY LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 43.GERMANY LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 44.FRANCE LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 45.FRANCE LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 46.FRANCE LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 47.FRANCE LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 48.UK LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 49.UK LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 50.UK LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 51.UK LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 52.ITALY LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 53.ITALY LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 54.ITALY LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 55.ITALY LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 56.SPAIN LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 57.SPAIN LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 58.SPAIN LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 59.SPAIN LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 60.REST OF EUROPE LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 61.REST OF EUROPE LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 62.REST OF EUROPE LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 63.REST OF EUROPE LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 64.EUROPE LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 65.EUROPE LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 66.EUROPE LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 67.EUROPE LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 68.ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 69.JAPAN LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 70.JAPAN LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 71.JAPAN LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 72.JAPAN LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 73.CHINA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 74.CHINA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 75.CHINA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 76.CHINA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 77.AUSTRALIA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 78.AUSTRALIA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 79.AUSTRALIA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 80.AUSTRALIA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 81.INDIA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 82.INDIA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 83.INDIA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 84.INDIA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 85.REST OF ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 86.REST OF ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 87.REST OF ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 88.REST OF ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 89.ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 90.ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 91.ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 92.ASIA-PACIFIC LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 93.LAMEA LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 94.BRAZIL LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 95.BRAZIL LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 96.BRAZIL LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 97.BRAZIL LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 98.SAUDI ARABIA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 99.SAUDI ARABIA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 100.SAUDI ARABIA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 101.SAUDI ARABIA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 102.SOUTH AFRICA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 103.SOUTH AFRICA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 104.SOUTH AFRICA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 105.SOUTH AFRICA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 106.REST OF LAMEA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 107.REST OF LAMEA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 108.REST OF LAMEA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 109.REST OF LAMEA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 110.LAMEA LATERAL FLOW ASSAY MARKET, BY TECHNIQUE, 2020–2030
TABLE 111.LAMEA LATERAL FLOW ASSAY MARKET, BY PRODUCT, 2020–2030
TABLE 112.LAMEA LATERAL FLOW ASSAY MARKET, BY APPLICATION, 2020–2030
TABLE 113.LAMEA LATERAL FLOW ASSAY MARKET, BY END USER, 2020–2030
TABLE 114.ABBOTT: COMPANY SNAPSHOT
TABLE 115.ABBOTT: PRODUCT SEGMENTS
TABLE 116.ABBOTT: PRODUCT PORTFOLIO
TABLE 117.ABBOTT: KEY DEVELOPMENTS
TABLE 118.BD: COMPANY SNAPSHOT
TABLE 119.BD: OPERATING SEGMENTS
TABLE 120.BD: PRODUCT PORTFOLIO
TABLE 121.BD: KEY DEVELOPMENTS
TABLE 122.BIOMÉRIEUX: COMPANY SNAPSHOT
TABLE 123.BIOMÉRIEUX: OPERATING SEGMENTS
TABLE 124.BIOMÉRIEUX: PRODUCT PORTFOLIO
TABLE 125.BIOMÉRIEUX: KEY DEVELOPMENTS
TABLE 126.BIO-RAD: COMPANY SNAPSHOT
TABLE 127.BIO-RAD: OPERATING BUSINESS SEGMENTS
TABLE 128.BIO-RAD: PRODUCT PORTFOLIO
TABLE 129.BIO-RAD: KEY DEVELOPMENTS
TABLE 130.DANAHER: COMPANY SNAPSHOT
TABLE 131.DANAHER: OPERATING BUSINESS SEGMENTS
TABLE 132.DANAHER: PRODUCT PORTFOLIO
TABLE 133.DANAHER: KEY DEVELOPMENTS
TABLE 134.ROCHE: COMPANY SNAPSHOT
TABLE 135.ROCHE: OPERATING SEGMENT
TABLE 136.ROCHE: PRODUCT PORTFOLIO
TABLE 137.ROCHE: KEY DEVELOPMENTS
TABLE 138.HOLOGIC: COMPANY SNAPSHOT
TABLE 139.HOLOGIC: OPERATING BUSINESS SEGMENTS
TABLE 140.HOLOGIC: PRODUCT PORTFOLIO
TABLE 141.HOLOGIC: KEY DEVELOPMENTS
TABLE 142.PERKINELMER: COMPANY SNAPSHOT
TABLE 143.PERKINELMER: OPERATING SEGMENTS
TABLE 144.PERKINELMER: PRODUCT PORTFOLIO
TABLE 145.SIEMENS: COMPANY SNAPSHOT
TABLE 146.SIEMENS: OPERATING SEGMENTS
TABLE 147.SIEMENS: PRODUCT PORTFOLIO
TABLE 148.SIEMENS: KEY DEVELOPMENTS
TABLE 149.THERMO FISCHER: COMPANY SNAPSHOT
TABLE 150.THERMO FISCHER: OPERATING SEGMENTS
TABLE 151.THERMO FISCHER: PRODUCT PORTFOLIO
TABLE 152.THERMO FISHER: KEY DEVELOPMENTS
LIST OF FIGURES
FIGURE 01.LATERAL FLOW ASSAY MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018–2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018–2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018–2021
FIGURE 06.HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.HIGH THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.HIGH COMPETITIVE OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF SANDWICH ASSAYS LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF HAND SANITIZER LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF MULTIPLEX DETECTION ASSAYS LATERAL FLOW ASSAY , BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF KITS & REAGENTS LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF LATERAL FLOW READERS LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.DIGITAL/MOBILE READERS MARKET, 2019–2027 ($MILLION)
FIGURE 19.BENCHTOP READERS MARKET, 2019–2027 ($MILLION)
FIGURE 20.MOBILE/SMARTPHONE READERS MARKET, 2019–2027 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF CLINICAL TESTING LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.INFECTIOUS DISEASE TESTING LATERAL FLOW ASSAY MARKET, 2020–2030, ($MILLION)
FIGURE 23.LATERAL FLOW READERS PERSONAL HYGINE TECHNIQUE MARKET, 2020–2030, ($MILLION)
FIGURE 24.PREGNANCY & FERTILITY TESTING LATERAL FLOW ASSAY MARKET, 2020–2030, ($MILLION)
FIGURE 25.CHOLESTEROL TESTING/LIPID PROFILE LATERAL FLOW ASSAY MARKET, 2020–2030, ($MILLION)
FIGURE 26.DRUG ABUSE TESTING LATERAL FLOW ASSAY MARKET, 2020–2030, ($MILLION)
FIGURE 27.OTHER CLINICAL TESTS LATERAL FLOW ASSAY MARKET, 2020–2030, ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF VETERINARY DIAGNOSTICS LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 29.COMPARATIVE ANALYSIS OF FOOD SAFETY & ENVIRONMENT TESTING LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF E-COMMERCE LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF HOSPITALS & CLINICS LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF DIAGNOSTIC LABORATORIES LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF HOME CARE LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 34.COMPARATIVE ANALYSIS OF PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 35.COMPARATIVE ANALYSIS OF OTHER END USERS LATERAL FLOW ASSAY MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 36.ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 37.ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 38.ABBOTT: REVENUE SHARE BY REGION, 2020(%)
FIGURE 39.BD: NET SALES, 2018–2020 ($MILLION)
FIGURE 40.BD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 41.BD: REVENUE SHARE BY REGION, 2020(%)
FIGURE 42.BIOMÉRIEUX: NET SALES, 2018–2020 ($MILLION)
FIGURE 43.BIOMÉRIEUX: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 44.BIOMÉRIEUX: REVENUE SHARE BY REGION, 2020(%)
FIGURE 45.BIO-RAD: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.BIO-RAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.BIO-RAD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 48.DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 49.DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 50.DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 51.ROCHE: NET SALES, 2018–2020 ($MILLION)
FIGURE 52.ROCHE: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 53.ROCHE: REVENUE SHARE BY REGION, 2020(%)
FIGURE 54.HOLOGIC: NET SALES, 2018–2020 ($MILLION)
FIGURE 55.HOLOGIC: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 56.HOLOGIC: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 57.PERKINELMER: NET SALES, 2018–2020 ($MILLION)
FIGURE 58.PERKINELMER: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 59.PERKINELMER: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 60.SIEMENS: NET SALES, 2018–2020 ($MILLION)
FIGURE 61.SIEMENS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 62.SIEMENS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 63.THERMO FISHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 64.THERMO FISHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 65.THERMO FISHER: REVENUE SHARE BY REGION, 2020(%)